Organization
Lena Napolitano, MD
1 clinical trial
Clinical trial
A Pilot Study to Assess the Safety, Tolerability and Efficacy of Selectin Inhibitor Uproleselan (GMI-1271) in Patients With COVID-19 PneumoniaStatus: Terminated, Estimated PCD: 2022-03-09